Kathlyn Lim

428 total citations
14 papers, 282 citations indexed

About

Kathlyn Lim is a scholar working on Transplantation, Epidemiology and Immunology. According to data from OpenAlex, Kathlyn Lim has authored 14 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Transplantation, 4 papers in Epidemiology and 4 papers in Immunology. Recurrent topics in Kathlyn Lim's work include Renal Transplantation Outcomes and Treatments (10 papers), Renal Diseases and Glomerulopathies (3 papers) and Pregnancy and Medication Impact (3 papers). Kathlyn Lim is often cited by papers focused on Renal Transplantation Outcomes and Treatments (10 papers), Renal Diseases and Glomerulopathies (3 papers) and Pregnancy and Medication Impact (3 papers). Kathlyn Lim collaborates with scholars based in United States and France. Kathlyn Lim's co-authors include Supreet Sethi, Stanley C. Jordan, Sanjeev Kumar, Ashley Vo, Alice Peng, Edmund Huang, Reiad Najjar, Jua Choi, Noriko Ammerman and Mieko Toyoda and has published in prestigious journals such as Transplantation, American Journal of Transplantation and Clinical Journal of the American Society of Nephrology.

In The Last Decade

Kathlyn Lim

13 papers receiving 276 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kathlyn Lim United States	9	171	101	99	87	35	14	282
John O’Regan Ireland	6	96 0.6×	177 1.8×	39 0.4×	131 1.5×	16 0.5×	9	298
F. Egidi United States	10	134 0.8×	81 0.8×	149 1.5×	38 0.4×	24 0.7×	23	292
Chiara Donadei Italy	9	59 0.3×	67 0.7×	46 0.5×	67 0.8×	12 0.3×	21	243
Joseph Rivalan France	8	63 0.4×	101 1.0×	38 0.4×	28 0.3×	43 1.2×	13	222
Saoussen Krid France	7	110 0.6×	227 2.2×	54 0.5×	232 2.7×	16 0.5×	23	372
TE Starzl United States	7	112 0.7×	53 0.5×	116 1.2×	51 0.6×	19 0.5×	20	276
Eric S. Campenot United States	7	91 0.5×	120 1.2×	57 0.6×	29 0.3×	27 0.8×	10	268
K Sonda Pakistan	10	284 1.7×	91 0.9×	209 2.1×	44 0.5×	11 0.3×	18	411
Tomek Kofman France	9	66 0.4×	164 1.6×	26 0.3×	37 0.4×	31 0.9×	13	242
Alexandre Dufay France	4	175 1.0×	49 0.5×	132 1.3×	67 0.8×	5 0.1×	6	260

Countries citing papers authored by Kathlyn Lim

Since Specialization

Citations

This map shows the geographic impact of Kathlyn Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathlyn Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathlyn Lim more than expected).

Fields of papers citing papers by Kathlyn Lim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathlyn Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathlyn Lim. The network helps show where Kathlyn Lim may publish in the future.

Co-authorship network of co-authors of Kathlyn Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Kathlyn Lim. A scholar is included among the top collaborators of Kathlyn Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathlyn Lim. Kathlyn Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Jordan, Stanley C., Noriko Ammerman, Jua Choi, et al.. (2022). Evaluation of Clazakizumab (Anti–Interleukin-6) in Patients With Treatment-Resistant Chronic Active Antibody-Mediated Rejection of Kidney Allografts. Kidney International Reports. 7(4). 720–731. 36 indexed citations

Vo, Ashley, Edmund Huang, Noriko Ammerman, et al.. (2021). Clazakizumab for desensitization in highly sensitized patients awaiting transplantation. American Journal of Transplantation. 22(4). 1133–1144. 30 indexed citations

Jordan, Stanley C., Noriko Ammerman, Jua Choi, et al.. (2020). The role of novel therapeutic approaches for prevention of allosensitization and antibody-mediated rejection. American Journal of Transplantation. 20. 42–56. 31 indexed citations

Jordan, Stanley C., Noriko Ammerman, Mieko Toyoda, et al.. (2020). CLAZAKIZUMAB (ANTI-IL-6 MONOCLONAL) TREATMENT OF PATIENTS WITH CHRONIC & ACTIVE ANTIBODY-MEDIATED REJECTION POST-KIDNEY TRANSPLANTATION (NCT03380377). Transplantation. 104(S3). S67–S68. 4 indexed citations

Sethi, Supreet, Sanjeev Kumar, Kathlyn Lim, & Stanley C. Jordan. (2020). Obinutuzumab is Effective for the Treatment of Refractory Membranous Nephropathy. Kidney International Reports. 5(9). 1515–1518. 60 indexed citations

Vo, Ashley, Noriko Ammerman, Edmund Huang, et al.. (2020). CLAZAKIZUMAB® (ANTI-IL-6) FOR DESENSITIZATION OF HIGHLY-HLA SENSITIZED PATIENTS AWAITING KIDNEY TRANSPLANT (NCT03380962). Transplantation. 104(S3). S104–S105. 6 indexed citations

Huang, Edmund, Matthew J. Gillespie, Noriko Ammerman, et al.. (2020). Donor-derived Cell-free DNA Combined With Histology Improves Prediction of Estimated Glomerular Filtration Rate Over Time in Kidney Transplant Recipients Compared With Histology Alone. Transplantation Direct. 6(8). e580–e580. 14 indexed citations

Jordan, Stanley C., Shili Ge, Mieko Toyoda, et al.. (2020). CLAZAKIZUMAB (ANTI-IL-6) INDUCES FOXP3+ TREGS IN HIGHLY HLA SENSITIZED PATIENTS RECEIVING HLAI KIDNEY TRANSPLANTATION (NCT03380962). Transplantation. 104(S3). S105–S105. 5 indexed citations

Huang, Edmund, Ashley Vo, Jua Choi, et al.. (2019). Three-Year Outcomes of a Randomized, Double-Blind, Placebo-Controlled Study Assessing Safety and Efficacy of C1 Esterase Inhibitor for Prevention of Delayed Graft Function in Deceased Donor Kidney Transplant Recipients. Clinical Journal of the American Society of Nephrology. 15(1). 109–116. 44 indexed citations

10.

Vo, Ashley, Olivier Aubert, Mark Haas, et al.. (2019). Clinical Relevance of Posttransplant DSAs in Patients Receiving Desensitization for HLA-incompatible Kidney Transplantation. Transplantation. 103(12). 2666–2674. 15 indexed citations

11.

Sethi, Supreet, Reiad Najjar, Alice Peng, et al.. (2019). Outcomes of Conversion From Calcineurin Inhibitor to Belatacept-based Immunosuppression in HLA-sensitized Kidney Transplant Recipients. Transplantation. 104(7). 1500–1507. 13 indexed citations

12.

Lim, Kathlyn, et al.. (2018). Cefotetan-Induced Hemolytic Anemia: Case Series and Review. Journal of Pharmacy Practice. 32(6). 679–682.

13.

Jordan, Stanley C., Noriko Ammerman, Jua Choi, et al.. (2018). Novel Therapeutic Approaches to Allosensitization and Antibody-mediated Rejection. Transplantation. 103(2). 262–272. 23 indexed citations

14.

Lim, Kathlyn, et al.. (2015). Two cases of cytarabine syndrome successfully resolved by desensitization.. PubMed. 25(1). 80–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact